UnitedHealth aims to reassure investors as profits plunge, DOJ investigates its Medicare business
1. UnitedHealth's stock price has halved since May due to management issues. 2. CEO Stephen Hemsley aims to rebuild investor trust amid setbacks. 3. Analysts focus on 2025 earnings guidance after a prior suspension. 4. Legal probes into billing practices raise investor concerns. 5. Optum Health margins have suffered due to recent reimbursement changes.